Pharmaceuticals News - Latest Updates & Headlines
India's pharmaceutical products may be subject to duties in future actions under US Trade Expansion Act of 1962: Report
New Delhi, April 3: The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the pharmaceutical sector, has raised concerns about potential future trade restrictions on drug exports.
Pharma tariff exemption to boost India-US trade ties: IPA's Secretary General Sudarshan Jain
New Delhi, April 3: The Indian Pharmaceutical Alliance (IPA) on Thursday welcomed the exclusion of pharmaceuticals from US tariffs, with Secretary General Sudarshan Jain emphasising the deepening of India-US trade ties under the Mission 500 initiative, aiming to double bilateral trade to USD 500 billion.
Indian pharmaceutical exports get reprieve from Trump's reciprocal tariffs
New York, April 3: Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get a reprieve from President Donald Trump’s reciprocal tariffs, according to the White House.
S. Korea seeks to boost animal medicine market to $2.7 billion by 2035
Seoul, April 2: South Korea will work to triple the size of the animal medicine market to 4 trillion won ($2.7 billion) by 2035 as part of efforts to foster new growth engines for the economy, the agriculture ministry said Wednesday.
Critical source of pharmaceuticals, machinery for us: New Zealand PM highlights India's growing economic sophistication
New Delhi, March 17: New Zealand Prime Minister Christopher Luxon on Monday acknowledged India's growing economic sophistication, highlighting the country's emergence as a critical source of pharmaceuticals and machinery for New Zealand.
Health Ministry issues Stop Activity and production order for Tapentadol, Carisoprodol drug combination
New Delhi, February 23: After a joint team from the Central Drugs Standard Control Organisation (CDSCO) and the state regulatory authority conducted an audit of Aveo Pharmaceuticals, the Union Health and Family Welfare Ministry has issued a Stop Activity Order that halts all operations at the company's premises.
Centre halts export of unapproved drug combo by Aveo Pharmaceuticals, seizes 1.3 cr tabs
New Delhi, Feb 23: The Health Ministry on Sunday said it has taken decisive action following reports highlighting the export of unapproved combination drugs, containing Tapentadol and Carisoprodol, by Indian pharmaceutical manufacturer, Aveo Pharmaceuticals in Mumbai to certain west African countries.
Quantum computing, AI to revolutionise drug discovery in India: Ex-ICMR chief
New Delhi, Feb 20: Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable the country to become a global hub for pharmaceutical advancements, said Dr. Balram Bhargava, Former Director General, ICMR.
Trump to announce tariffs on cars, chips, pharmaceuticals 'over the next month or sooner'
Washington, Feb 20: US President Donald Trump has said that he will announce tariffs on cars, semiconductors, and pharmaceuticals "over the next month or sooner" as he is pushing for new levies to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
India, Myanmar explore trade opportunities in pharmaceuticals, agriculture, petroleum
New Delhi, February 15: India and Myanmar on February 14, discussed possibilities in areas of pharmaceuticals, pulses & beans, petroleum products and greater use of the recently launched Rupee-Kyat Trade Settlement Mechanism to foster mutual growth.
India's CDMO market set to double by 2028 amid Asia's healthcare boom
New Delhi, February 9: India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to expand from USD 7 billion to USD 14 billion by 2028, capturing 4-5 per cent of the global market, according to BCG report.
WHO hails India's leadership in pharmacopoeial standard-setting
New Delhi, Feb 5: India's leadership in pharmacopoeial standard setting is commendable, said Dr. Roderico H.Ofrin, WHO Representative to India, on Wednesday. Ofrin also stressed the importance of regulatory harmonisation in ensuring patient safety and public health.
Budget 2025: Here's what all will get cheaper and costlier as FM rejigs basic customs duties
New Delhi, February 1: For the layperson, the highlight of the Union Budget has always remained on what all have become cheaper and which of them has got costlier to buy.
US FDA approves painkillers designed to eliminate risk of addiction associated with opioids
New York, Feb 1: US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment
Seoul, Jan 31: Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administration (FDA).
IT services, Pharma sector PAT to grow by 5.8 pc in 3Q FY25: JM Financial
New Delhi, January 11: The JM Financial coverage universe is poised to report a 5.8 per cent year-on-year (YoY) growth in profit after tax (PAT) for the third quarter of FY25, driven by robust performances in IT services and pharmaceuticals.
UAE: DUPHAT 2025 concludes with AED9.35 billion in deals
Dubai, January 10: The 30th edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition - DUPHAT 2025 concluded successfully, recording AED9.35 billion in direct and indirect trade deals over the past three days.
Jan Aushadhi Kendras sees over Rs 1,255-cr sales of affordable medicines till Nov: PMO
New Delhi, Jan 7: Jan Aushadhi outlets made over Rs 1,255 crore in sales of medicines till November, the Prime Minister's Office said on Tuesday.